Search
for
Sort by
Research 361–390 of 1000+
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series
- Alopecia and Hair Damage Induced by Oncological Therapy
- Gefitinib-induced hair alterations: Figure 1
- Alopecia areata universalis in a dog
- Child with De Novo t(1;6)(p22.1;p22.1) translocation and features of ectodermal dysplasia with hypodontia and developmental delay
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Filamin A Mediates Wound Closure by Promoting Elastic Deformation and Maintenance of Tension in the Collagen Matrix
- Marie-unna hereditary hypotrichosis
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Long‐Term Follow‐Up of Previously Reported Case of Trichomegaly Associated with Alopecia Areata in a 3‐Year‐Old Girl
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- The <i>Girl with a Pearl Earring</i> : A dermatological puzzle
- Alopecia Areata: Clinical Treatment
- Congenital atrichia associated with nevus flammeus: A rare association
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Prevalence of <i>Demodex</i> spp. in students and employees of the Pomeranian Medical University in Szczecin
- Treatment of Chemotherapy Induced Alopecia
- Pili Annulati: A case series and proposal for classification
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Demographics and Disease Characteristics of Patients with Alopecia Areata with Comorbid Atopic Dermatitis, Vitiligo or Anxiety/Depression: TARGET-DERM AA
- 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- Common genetic hair shaft abnormalities may be visualized by light and electron microscope
- CLINICAL PEARLS
- OVS Announces